In letters to the US Food and Drug Administration (part of the HHS) and the USDA’s Food and Nutrition Service (FNS), the two ...

Health Secretary Robert Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.

Pfizer CEO says RFK Jr.'s appointment was not up to him, though he has found common ground with the vaccine skeptic.

Kennedy said hormone therapy could "reduce the risks of cardiovascular disease and mortality by as much as 50%, Alzheimer's ...

Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...

This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...

This year, many in Congress have been working on bills to reform the Generally Recognized As Safe (GRAS) protocols for food ...

Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal ...

The agency says newer evidence shows hormone therapy risks depend on age, timing and dose• Some call it a major step toward ...

This episode of Pharma Pulse explores how regulators modernize safety information for hormone therapy, new data that ...

Dr. Lauren Streicher, a professor of obstetrics and gynecology at Northwestern, has some reservations about federal health ...

FDA Commissioner Marty Makary and some other doctors have long criticized the current warning for these drugs as outdated and ...